×

RNA-guided human genome engineering

  • US 9,023,649 B2
  • Filed: 06/30/2014
  • Issued: 05/05/2015
  • Est. Priority Date: 12/17/2012
  • Status: Active Grant
First Claim
Patent Images

1. A method of altering a eukaryotic cell comprisingproviding to the eukaryotic cell guide RNA sequences complementary to target nucleic acid sequences,providing to the cell a Cas9 protein having inactive nuclease domains that interacts with the guide RNA sequence and binds to the target nucleic acid sequences in a site specific manner,wherein the Cas 9 has a FokI nuclease domain attached thereto,wherein a target nucleic acid sequence is cleaved upon FokI nuclease domain dimerization of adjacent guide RNA sequence and Cas9 protein co-localization complexes.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×